Marcus Deichmann
Postdoc
Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kongens Lyngby
Biography
Marcus Deichmann is a synthetic biologist working at the intersection of microbial engineering, immunology, and cell–cell communication. His research focuses on building engineered yeast systems that can mimic and control key aspects of human immune signalling, allowing researchers to study how immune cells recognise, interpret, and respond to disease-relevant signals. A central theme of his work is the development of synthetic platforms that make complex immune processes experimentally accessible, reproducible, and quantifiable. Deichmann has contributed to the creation of yeast-based tools for probing CAR T-cell recognition of cancer antigens and for dissecting G-protein–coupled receptor signalling in a highly controlled setting. His work combines synthetic biology, surface display technologies, and high-throughput screening to bridge basic molecular mechanisms with applications in immunotherapy and precision medicine.
